ALIBABA HLTH INFO.T.HD-01
ALIBABA HLTH INFO.T.HD-01/ BMG0171K1018 /
TWY
|
17/05/2024 12:42:54
|
Diferencia
+0.0287
|
Volumen |
Bid16:32:14 |
Ask20:06:05 |
Capitalización de mecado |
Dividendo A. |
P/E Ratio |
|
0.3978EUR
|
+7.78%
|
7,659
Volumen de negocios: 3,031.5679 |
-Volumen de oferta: - |
-Tamaño/ Volumen/ Formato de Ask: - |
5.31 mil millonesEUR |
- |
- |
Descripción de negocio
Alibaba Health Information Technology Limited engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. Alibaba Health Information Technology Limited was incorporated in 1998 and is based in Causeway Bay, Hong Kong.
Consejo de gestión & Consejo de supervisión
| CEO |
| Zhu Shunyan |
| Consejo de gestión |
| Tu Yanwu, Shen Difan, Zhang Hua, Yin Rui, Deng Yan |
| Consejo de supervisión |
| Zhu Shunyan, Shen Difan, Tu Yanwu, Huang Jiaojiao, Dr. Shao Rong, Wu May Yihong, Huang Yi Fei, (Vanessa), Xu Haipeng |
Datos de la empresa
| Nombre: |
Alibaba Health Information Technology Ltd |
| Dirección: |
Tower One, 26th Floor Times Square 1 Matheson Street,Causeway Bay, Hong Kong |
| Teléfono: |
+86-852-2215-5100 |
| Fax: |
+86-852-2215-5200 |
| E-mail: |
alihealth_info@alibaba-inc.com
|
| Internet: |
https://www.alihealth.cn/ |
| Industria: |
Healthcare |
| Sector: |
Pharmaceutical Industry |
| Subsector: |
Pharmaceuticals |
| Fin del año financiero: |
31/03 |
| Acciones de libre circulación: |
- |
| Fecha de OPI: |
06/07/1972 |
